Kidney Disease Awareness and Knowledge among Survivors ofAcute Kidney Injury.


Journal

American journal of nephrology
ISSN: 1421-9670
Titre abrégé: Am J Nephrol
Pays: Switzerland
ID NLM: 8109361

Informations de publication

Date de publication:
2019
Historique:
received: 18 12 2018
accepted: 18 03 2019
pubmed: 18 4 2019
medline: 7 7 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

Acute kidney injury (AKI) survivors are at risk for chronic kidney disease, recurrent AKI, and cardiovascular disease. The transition from hospital to ambulatory care is an opportunity to reduce these sequelae by launching self-care plans through effective patient education. How well AKI survivors are informationally prepared to apply kidney-specific self-care is unknown. The purpose of this study was to identify awareness and disease-specific knowledge among AKI survivors. We performed a cross-sectional survey of AKI-related awareness and knowledge in 137 patients with Kidney Disease Improving Global Outcomes Stage II or III AKI near the time of hospital discharge. Patients were asked (1) "Did you experience AKI while in the hospital?" and (2) "Do you have a problem with your kidney health?" Objective knowledge of AKI was evaluated with a 15-item adapted version of the validated Kidney Knowledge Survey that included topics such as common causes, risk factors, and how AKI is diagnosed. Median age was 54 (interquartile range 43-63) and 81% were white. Eighty percent of patients were unaware that they had experienced AKI and 53% were both unaware they had experienced AKI or had a "problem with their kidneys." Multivariable logistic regression identified being male and lack of nephrology consult as predictors of unawareness with ORs of 3.92 (95% CI 1.48-10.33) and 5.10 (95% CI 1.98-13.13), respectively. Less than 50% recognized nonsteroidal anti-inflammatory drugs, contrast, or phosphate-based cathartics as risk factors for AKI. Two-thirds of patients did not agree that they knew a lot about AKI and more than 80% desired more information. Most patients with moderate to severe AKI are unaware of their condition, lack understanding of risk factors for recurrent AKI, and desire more information. Patient-centered communication to optimize awareness, understanding, and care will require coordinated educational strategies throughout the continuum of AKI care.

Sections du résumé

BACKGROUND
Acute kidney injury (AKI) survivors are at risk for chronic kidney disease, recurrent AKI, and cardiovascular disease. The transition from hospital to ambulatory care is an opportunity to reduce these sequelae by launching self-care plans through effective patient education. How well AKI survivors are informationally prepared to apply kidney-specific self-care is unknown. The purpose of this study was to identify awareness and disease-specific knowledge among AKI survivors.
METHODS
We performed a cross-sectional survey of AKI-related awareness and knowledge in 137 patients with Kidney Disease Improving Global Outcomes Stage II or III AKI near the time of hospital discharge. Patients were asked (1) "Did you experience AKI while in the hospital?" and (2) "Do you have a problem with your kidney health?" Objective knowledge of AKI was evaluated with a 15-item adapted version of the validated Kidney Knowledge Survey that included topics such as common causes, risk factors, and how AKI is diagnosed.
RESULTS
Median age was 54 (interquartile range 43-63) and 81% were white. Eighty percent of patients were unaware that they had experienced AKI and 53% were both unaware they had experienced AKI or had a "problem with their kidneys." Multivariable logistic regression identified being male and lack of nephrology consult as predictors of unawareness with ORs of 3.92 (95% CI 1.48-10.33) and 5.10 (95% CI 1.98-13.13), respectively. Less than 50% recognized nonsteroidal anti-inflammatory drugs, contrast, or phosphate-based cathartics as risk factors for AKI. Two-thirds of patients did not agree that they knew a lot about AKI and more than 80% desired more information.
CONCLUSIONS
Most patients with moderate to severe AKI are unaware of their condition, lack understanding of risk factors for recurrent AKI, and desire more information. Patient-centered communication to optimize awareness, understanding, and care will require coordinated educational strategies throughout the continuum of AKI care.

Identifiants

pubmed: 30995659
pii: 000499862
doi: 10.1159/000499862
pmc: PMC6679978
mid: NIHMS1022042
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-459

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079341
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007569
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK103935
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK114566
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK114809
Pays : United States

Informations de copyright

© 2019 S. Karger AG, Basel.

Références

Ann Intern Med. 2009 Feb 3;150(3):178-87
pubmed: 19189907
Adv Chronic Kidney Dis. 2013 Jul;20(4):311-9
pubmed: 23809283
Am J Kidney Dis. 2013 Jul;62(1):23-32
pubmed: 23540261
Am J Kidney Dis. 2016 Jan;67(1):31-9
pubmed: 26385817
Semin Dial. 2016 Mar-Apr;29(2):135-43
pubmed: 26858008
J Epidemiol Community Health. 2007 Dec;61(12):1086-90
pubmed: 18000132
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
Am J Med. 2017 Feb;130(2):163-172.e4
pubmed: 27751901
J Am Soc Nephrol. 2012 Feb;23(2):305-12
pubmed: 22158435
Kidney Int. 2012 Mar;81(5):442-8
pubmed: 22113526
BMC Public Health. 2015 Jun 26;15:589
pubmed: 26112264
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Hosp Med. 2015 Sep;10(9):619-22
pubmed: 26014973
Home Health Care Serv Q. 2006;25(3-4):39-53
pubmed: 17062510
J Am Soc Nephrol. 2016 Apr;27(4):1190-200
pubmed: 26264853
J Am Geriatr Soc. 2004 Nov;52(11):1817-25
pubmed: 15507057
Ochsner J. 2010 Spring;10(1):38-43
pubmed: 21603354
Kidney Int. 2008 Nov;74(9):1178-84
pubmed: 18668024
Mayo Clin Proc. 2005 Aug;80(8):991-4
pubmed: 16092576
J Health Popul Nutr. 2017 May 25;36(1):23
pubmed: 28545582
Am J Kidney Dis. 2011 Mar;57(3):387-95
pubmed: 21168943
Clin J Am Soc Nephrol. 2011 Nov;6(11):2567-72
pubmed: 21903988
JAMA. 2004 Mar 17;291(11):1358-67
pubmed: 15026403
Clin J Am Soc Nephrol. 2013 Mar;8(3):476-83
pubmed: 23471414
Adv Chronic Kidney Dis. 2016 Jul;23(4):231-9
pubmed: 27324676
Can J Kidney Health Dis. 2019 Feb 21;6:2054358119830700
pubmed: 30815269
QJM. 2013 Apr;106(4):323-32
pubmed: 23345468
Can J Kidney Health Dis. 2016 Feb 26;3:13
pubmed: 26925249
Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7
pubmed: 19745202
Clin Kidney J. 2015 Aug;8(4):462-8
pubmed: 26251719
J Emerg Med. 1997 Jan-Feb;15(1):1-7
pubmed: 9017479
J Am Geriatr Soc. 2003 Oct;51(10):1451-4
pubmed: 14511167
J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1540-7
pubmed: 25899157
Contrib Nephrol. 2011;171:68-73
pubmed: 21625092
BMC Health Serv Res. 2016 Aug 30;16:449
pubmed: 27577888
J Gen Intern Med. 2014 Jan;29(1):119-26
pubmed: 23918160
Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):639-47
pubmed: 15545332
BMC Nephrol. 2016 Nov 24;17(1):189
pubmed: 27881100
Am J Kidney Dis. 2013 Apr;61(4):536-9
pubmed: 23312722
Kidney Int. 2011 Jun;79(12):1361-9
pubmed: 21430640
JAMA Intern Med. 2013 Oct 14;173(18):1715-22
pubmed: 23958851
J Am Soc Nephrol. 2013 Jan;24(1):37-42
pubmed: 23222124
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1753-1761
pubmed: 29025786
Ann Emerg Med. 2009 Apr;53(4):454-461.e15
pubmed: 18619710
Kidney Int. 2014 Mar;85(3):686-92
pubmed: 24067435
Arch Intern Med. 2006 Sep 25;166(17):1822-8
pubmed: 17000937
Kidney Int. 2011 Dec;80(12):1344-51
pubmed: 21832984
Lancet. 2010 Dec 18;376(9758):2096-103
pubmed: 21094997

Auteurs

Edward D Siew (ED)

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Center for Kidney Diseases (VCKD) and Integrated Program for AKI Research (VIP-AKI), Nashville, Tennessee, USA, edward.siew@vumc.org.
Tennessee Valley Healthcare System, Veteran's Health Administration, Nashville, Tennessee, USA, edward.siew@vumc.org.

Sharidan K Parr (SK)

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Center for Kidney Diseases (VCKD) and Integrated Program for AKI Research (VIP-AKI), Nashville, Tennessee, USA.
Tennessee Valley Healthcare System, Veteran's Health Administration, Nashville, Tennessee, USA.

Marcus G Wild (MG)

Vanderbilt University, Department of Psychological Sciences, Nashville, Tennessee, USA.

Swee-Ling Levea (SL)

Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Kermaan G Mehta (KG)

Department of Surgery, New York Methodist Hospital, Brooklyn, New York, USA.

Ebele M Umeukeje (EM)

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Center for Kidney Diseases (VCKD) and Integrated Program for AKI Research (VIP-AKI), Nashville, Tennessee, USA.
Vanderbilt Center for Effective Health Communication, Nashville, Tennessee, USA.

Samuel A Silver (SA)

Division of Nephrology, Queen's University, Kingston, Ontario, Canada.

T Alp Ikizler (TA)

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Center for Kidney Diseases (VCKD) and Integrated Program for AKI Research (VIP-AKI), Nashville, Tennessee, USA.
Tennessee Valley Healthcare System, Veteran's Health Administration, Nashville, Tennessee, USA.

Kerri L Cavanaugh (KL)

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Center for Kidney Diseases (VCKD) and Integrated Program for AKI Research (VIP-AKI), Nashville, Tennessee, USA.
Tennessee Valley Healthcare System, Veteran's Health Administration, Nashville, Tennessee, USA.
Vanderbilt Center for Effective Health Communication, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH